| Literature DB >> 28840197 |
Srinivasan Beddhu1,2, Xiaorui Chen2, Guo Wei2, Dominic Raj3, Kalani L Raphael1,2, Robert Boucher2, Michel B Chonchol4, Maureen A Murtaugh2, Tom Greene2,5.
Abstract
INTRODUCTION: It is unknown whether the criteria used to define Protein-energy wasting (PEW) syndrome in dialysis patients reflect protein or energy wasting in the general and moderate CKD populations.Entities:
Year: 2017 PMID: 28840197 PMCID: PMC5563827 DOI: 10.1016/j.ekir.2017.01.002
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
ISRNM PEW syndrome criteria and categoriesa
| Categories | Criteria within categories |
|---|---|
| Low serum chemistry | Serum albumin < 3.8 g/dl |
| Low body mass | BMI < 23 kg/m2 |
| Low muscle mass | Muscle wasting: reduced muscle mass 5% over 3 mo or 10% over 6 mo |
| Low dietary intakeˆ | Dietary protein intake < 0.60 g/kg/d |
BMI, body mass index; CKD, chronic kidney disease; ISRNM, International Society of Renal Nutrition and Metabolism; NHANES, National Health and Nutrition Examination Survey; PEW, protein–energy wasting.
The term “criteria” refers to each individual variable, whereas “category” refers to grouping of criteria as serum chemistry, body mass, muscle mass, and dietary intake categories.
ISRNM panel used bromcresol green method. In NHANES, serum albumin was measured by bromcresol purple method (see text for details).
Data were not available in NHANES; hence, this criterion was not used in this analysis.
ISRNM panel used BMI < 23 kg/m2 in dialysis patients. The current study used BMI < 20 kg/m2 (∼fifth percentile) in non-CKD and moderate CKD populations.
ISRNM panel used 10% weight loss over 6 months.
There were no patients with body fat < 10%; hence, this criterion was not used in this analysis.
Baseline clinical characteristicsa by number of PEW syndrome categories in entire cohort (N = 11,834)
| Number of PEW syndrome categories | 0 (43.15%) | 1 (46.85%) | 2 (9.41%) | ≥3 (0.69%) |
|---|---|---|---|---|
| Demographics | ||||
| Age (yr) | 43.2 ± 11.8 | 48.4 ± 14.3 | 46.8 ± 14.5 | 50.8 ± 16.6 |
| Male (%) | 60.8% | 43.9% | 35.7% | 32.3% |
| African American race (%) | 8.4% | 10.8% | 8.1% | 13.6% |
| ≥High school education (%) | 82.2% | 78.2% | 78.2% | 60.0% |
| Clinical parameters | ||||
| Myocardial infarction (%) | 2.6% | 4.2% | 4.6% | 6.6% |
| Congestive heart failure (%) | 1.1% | 3.0% | 2.1% | 4.6% |
| Stroke (%) | 1.3% | 3.1% | 2.6% | 2.5% |
| Diabetes (%) | 5.0% | 9.7% | 7.4% | 6.9% |
| Smoking (%) | 50.8% | 50.6% | 47.6% | 61.7% |
| Alcohol use (%) | 74.6% | 65.9% | 64.7% | 63.1% |
| Hypertension (%) | 23.4% | 35.4% | 25.9% | 35.2% |
| Lung disease (%) | 5.6% | 7.9% | 10.5% | 16.9% |
| Cancer (%) | 6.4% | 9.2% | 9.2% | 8.1% |
| C-reactive protein (mg/l) | 1.6 (0.7−3.5) | 2.3 (0.9−5.0) | 1.3 (0.5−3.2) | 1.5 (0.4−6.1) |
| Serum bicarbonate (mmol/l) | 24.1 ± 1.7 | 24.1 ± 1.9 | 24.2 ± 1.9 | 24.6 ± 2.1 |
| eGFR (ml/min/1.73 m2) | 95.6 ± 15.0 | 92.0 ± 18.4 | 94.6 ± 19.3 | 89.7 ± 23.7 |
| PEW variables | ||||
| Serum albumin (g/dl) | 4.4 ± 0.2 | 4.3 ± 0.3 | 4.3 ± 0.3 | 4.2 ± 0.5 |
| Total cholesterol (mg/dl) | 202.6 ± 32.9 | 204.1 ± 35.2 | 196.2 ± 32.6 | 194.2 ± 51.7 |
| Body mass index (kg/m2) | 27.0 ± 3.2 | 28.5 ± 4.8 | 22.7 ± 3.7 | 19.4 ± 1.7 |
| Weight change compared to last yr (%) | 1.1 ± 5.8 | 0.9 ± 7.8 | −1.8 ± 7.5 | −2.2 ± 6.7 |
| Body fat (%) | 30.3 ± 6.0 | 35.2 ± 8.1 | 28.7 ± 7.3 | 26.0 ± 6.5 |
| Mid-arm muscle circumference (cm) | 27.3 ± 2.9 | 26.3 ± 3.4 | 22.0 ± 2.4 | 21.1 ± 1.8 |
| Dietary protein intake (g/kg/d) | 1.2 (1.0−1.6) | 0.8 (0.6−1.1) | 0.9 (0.7−1.4) | 0.7 (0.5−0.9) |
| Dietary energy intake (kcal/kg/d) | 33.5 (28.8−40.8) | 20.7 (16.3−24.7) | 23.8 (19.3−38.3) | 19.9 (18.0−22.3) |
Data are mean ± SD, median (interquartile range), or proportion as appropriate, adjusted by survey weight. All P values <0.001, except smoking (P = 0.14) and serum bicarbonate (P = 0.04). eGFR, estimated glomerular filtration rate; PEW, protein–energy wasting.
Survey weight−adjusted means, medians, or proportions.
Prevalence and associationsa of individual PEW criteria with lean body mass and fat mass in entire cohort (N = 11,834)
| Prevalence | Lean body mass (kg) regression coefficient | Fat mass (kg) regression coefficient | |
|---|---|---|---|
| Low serum albumin (<3.25 g/dl) | 0.6% | –3.5 (–7.5 to 0.4) | –3.7 (–7.0 to –0.3) |
| Low serum cholesterol (<100 mg/dl) | 0.2% | –2.5 (–6.8 to 1.8) | –4.6 (–9.7 to 0.5) |
| Low body mass index (<20 kg/m2) | 5.9% | –9.7 (–10.3 to –9.1) | –14.2 (–14.5 to –13.8) |
| Unintentional weight loss (>10% over 1 yr) | 2.4% | –2.2 (–3.3 to –1.0) | –3.4 (–4.8 to –1.9) |
| Low body fat % (<10%) | 0 | NA | NA |
| Low mid-arm muscle circumference area | 17.1% | –8.6 (–9.0 to –8.3) | –8.3 (–8.8 to –7.9) |
| Low dietary protein intake (<0.60 g/kg/d) | 15.2% | 3.6 (3.0 to 4.2) | 6.4 (5.8 to 7.1) |
| Low dietary energy intake (<25 kcal/kg/d) | 42.7% | 4.3 (3.9 to 4.7) | 7.3 (6.9 to 7.7) |
CI, confidence interval; NA, not applicable as none had body fat % <10%; NHANES, National Health and Nutrition Examination Survey; PEW, protein–energy wasting.
NHANES survey weight adjusted.
Each cell represents a separate model adjusted for age, gender, race, education, smoking, and alcohol use.
Fifth percentile of BMI was 19.93 kg/m2.
Prevalence and associationsa of individual PEW criteria with lean body mass and fat mass in CKD subpopulation (n = 1156)
| Prevalence | Lean body mass (kg) regression coefficient | Fat mass (kg) regression coefficient | |
|---|---|---|---|
| Low serum albumin (<3.25 g/dl) | 1.3% | –1.1 (–10.2 to 7.9) | 0.3 (–6.8 to 7.3) |
| Low serum cholesterol (<100 mg/dl) | 0.03% | –6.9 (–8.6 to –5.2) | –8.6 (–10.4 to –6.8) |
| Low body mass index (<20 kg/m2) | 4.9% | –9.3 (–10.5 to –8.1) | –15.4 (–16.9 to –13.8) |
| Unintentional weight loss (>10% over 1 yr) | 5.4% | –1.8 (–4.6 to 1.1) | –4.9 (–8.7 to –1.1) |
| Low body fat % (<10%) | 0 | NA | NA |
| Low mid-arm muscle circumference area | 15.8% | –7.7 (–9.0 to –6.4) | –8.8 (–10.1 to –7.5) |
| Low dietary protein intake (<0.60 g/kg/d) | 25.8% | 3.4 (2.3 to 4.5) | 6.0 (4.5 to 7.4) |
| Low dietary energy intake (<25 kcal/kg/d) | 65.4% | 4.7 (3.6 to 5.8) | 7.5 (6.1 to 9.0) |
CI, confidence interval; CKD, chronic kidney disease; NA, not applicable as none had body fat % <10%; NHANES, National Health and Nutrition Examination Survey; PEW, protein–energy wasting.
NHANES survey weight adjusted.
Each cell represents a separate model adjusted for age, gender, race, education, smoking, and alcohol use.
Fifth percentile of body mass index in entire cohort was 19.93 kg/m2.
Body size and body composition characteristics by number of PEW categories defined by nondietary categories alone (N = 11,834)
| 0 Nondietary | 1 Nondietary (16.57%) | 2 Nondietary | 3 Nondietary | |
|---|---|---|---|---|
| Body mass index | 28.5 ± 4.0 | 23.8 ± 2.9 | 19.0 ± 1.4 | 17.2 ± 0.8 |
| Mid-arm muscle circumference (cm2) | 27.3 ± 3.1 | 22.8 ± 2.5 | 21.0 ± 1.9 | 20.3 ± 0.8 |
| Lean body mass (kg) | 52.3 ± 9.4 | 43.2 ± 7.0 | 37.6 ± 5.5 | 37.8 ± 2.9 |
| Fat mass (kg) | 28.3 ± 7.8 | 21.8 ± 5.4 | 13.6 ± 2.7 | 9.2 ± 3.1 |
PEW, protein–energy wasting.
Survey weight−adjusted proportions.
Body size and body composition of patients with dietary category alone compared to those with none of the categories or those with dietary category with additional nondietary categories (n = 10,137)a
| 0 Dietary or nondietary | Dietary alone | Dietary + 1 nondietary | Dietary + 2 or more nondietary | |
|---|---|---|---|---|
| Body mass index (kg/m2) | 27.0 ± 3.1 | 30.2 ± 4.4 | 25.4 ± 3.4 | 19.5 ± 1.6 |
| Mid-arm muscle circumference (cm2) | 27.3 ± 2.9 | 27.3 ± 3.2 | 22.8 ± 2.6 | 21.1 ± 1.8 |
| Lean body mass (kg) | 52.6 ± 8.5 | 51.9 ± 10.2 | 43.0 ± 7.1 | 37.0 ± 5.4 |
| Fat mass (kg) | 25.0 ± 6.0 | 32.3 ± 8.4 | 25.1 ± 6.0 | 14.7 ± 2.8 |
Patients with only nondietary categories without dietary category being present were not included in this table.
Survey weight−adjusted proportions.
Figure 1Associations of the number of protein−energy wasting (PEW) syndrome categories with lean body mass and fat mass measured by dual-energy x-ray absorptiometry scans in multivariate linear regression models in the entire cohort (N = 11,834). (a) Nondietary categories alone and lean body mass. (b) Dietary category included and lean body mass. (c) Nondietary categories alone and fat mass. (d) Dietary category included and fat mass.
Figure 2Associations of the number of protein−energy wasting (PEW) syndrome categories with lean body mass and fat mass measured by dual-energy x-ray absorptiometry scans in multivariate linear regression models in the chronic kidney disease (CKD) subpopulation (n = 1156). (a) Nondietary categories alone and lean body mass. (b) Dietary category included and lean body mass. (c) Nondietary categories alone and fat mass. (d) Dietary category included and fat mass.
Figure 3Mortality associations of the number of protein−energy wasting (PEW) syndrome categories with mortality in multivariate Cox regression models in the entire cohort (N = 11,834) and chronic kidney disease (CKD) subpopulation (n = 1156). (a) Nondietary categories alone and mortality in the entire cohort. (b) Dietary category included and mortality in the entire cohort. (c) Nondietary categories alone and mortality in the CKD subpopulation.* (d) Dietary category included and mortality in the CKD subpopulation.$∗There was only 1 observation with 3 nondietary categories present in the CKD subpopulation and hence this observation was included as ≥2 categories in this figure). $There were only 19 observations with ≥3 categories (1 dietary and 2 or 3 nondietary) present in the CKD subpopulation and hence these observations were included as ≥2 categories in this figure.